• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便免疫化学试验用于结直肠癌筛查时,对另一种粪便取样收集装置的满意度更高:一项横断面研究。

Higher satisfaction with an alternative collection device for stool sampling in colorectal cancer screening with fecal immunochemical test: a cross-sectional study.

机构信息

National Cancer Control Institute, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang, 10408, Republic of Korea.

College of Nursing, Korea University, Seoul, South Korea.

出版信息

BMC Cancer. 2018 Apr 2;18(1):365. doi: 10.1186/s12885-018-4290-0.

DOI:10.1186/s12885-018-4290-0
PMID:29609647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5879644/
Abstract

BACKGROUND

Identifying preferences for stool collection devices may help increase uptake rates for colorectal cancer screening via fecal immunochemical test (FIT). This study surveyed satisfaction with different devices utilized to collect stool samples for FIT: a conventional container and a sampling bottle (Eiken OC-Sensor).

METHODS

This cross-sectional study was conducted at the National Cancer Center, Korea. Participants aged 50-74 years who used either a conventional container or a sampling bottle to collect a stool sample for FIT were asked to complete a questionnaire designed to survey their satisfaction with the stool collection process and their intentions to undergo FIT in subsequent screening rounds. In total, 1657 participants (1224 conventional container, 433 sampling bottle) were included for analysis.

RESULTS

Satisfaction with the sampling bottle was higher than that with the conventional container (79.9% vs.73.0%, p = 0.005, respectively; aOR = 1.52, 95% CI: 1.16-2.00). Participants satisfied with the sampling bottle were more likely to be female, be of younger age (50-64 years old), have higher household income, and have prior experience with FIT. Intentions to undergo subsequent screening were stronger among those given the sampling bottle than those given the conventional container (aOR = 1.78, 95% CI: 1.28-2 .48).

CONCLUSIONS

Satisfaction with the stool collection process was higher with the sampling bottle. However, additional studies are needed to validate whether the increased satisfaction and stronger intentions to undergo subsequent screening with the sampling bottle could actually lead to increased uptake in subsequent rounds, along with analysis of the device's cost effectiveness.

摘要

背景

确定对粪便采集装置的偏好可能有助于通过粪便免疫化学检测(FIT)提高结直肠癌筛查的参与率。本研究调查了参与者对用于收集 FIT 粪便样本的不同装置的满意度:传统容器和采样瓶(Eiken OC-Sensor)。

方法

这是一项在韩国国家癌症中心进行的横断面研究。参与者年龄在 50-74 岁之间,他们使用传统容器或采样瓶收集 FIT 粪便样本,要求他们完成一份问卷,旨在调查他们对粪便采集过程的满意度以及他们在后续筛查轮次中接受 FIT 的意愿。共有 1657 名参与者(1224 名使用传统容器,433 名使用采样瓶)被纳入分析。

结果

对采样瓶的满意度高于传统容器(分别为 79.9%和 73.0%,p=0.005;aOR=1.52,95%CI:1.16-2.00)。对采样瓶满意的参与者更有可能是女性、年龄在 50-64 岁之间、家庭收入较高且有 FIT 既往史。与使用传统容器的参与者相比,使用采样瓶的参与者接受后续筛查的意愿更强(aOR=1.78,95%CI:1.28-2.48)。

结论

对粪便采集过程的满意度采样瓶更高。然而,需要进一步的研究来验证采样瓶带来的更高满意度和更强的接受后续筛查的意愿是否真的可以提高后续轮次的参与率,同时还需要分析该装置的成本效益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de7d/5879644/072e97471d93/12885_2018_4290_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de7d/5879644/072e97471d93/12885_2018_4290_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de7d/5879644/072e97471d93/12885_2018_4290_Fig1_HTML.jpg

相似文献

1
Higher satisfaction with an alternative collection device for stool sampling in colorectal cancer screening with fecal immunochemical test: a cross-sectional study.粪便免疫化学试验用于结直肠癌筛查时,对另一种粪便取样收集装置的满意度更高:一项横断面研究。
BMC Cancer. 2018 Apr 2;18(1):365. doi: 10.1186/s12885-018-4290-0.
2
Performance of the Fecal Immunochemical Test for Colorectal Cancer Screening Using Different Stool-Collection Devices: Preliminary Results from a Randomized Controlled Trial.使用不同粪便收集装置进行粪便免疫化学检测用于结直肠癌筛查的性能:一项随机对照试验的初步结果
Gut Liver. 2016 Nov 15;10(6):925-931. doi: 10.5009/gnl15479.
3
The effect of changing stool collection processes on compliance in nationwide organized screening using a fecal occult blood test (FOBT) in Korea: study protocol for a randomized controlled trial.韩国粪便潜血试验(FOBT)全国性组织筛查中改变粪便采集流程对依从性的影响:一项随机对照试验的研究方案
Trials. 2014 Nov 26;15:461. doi: 10.1186/1745-6215-15-461.
4
Effect of Imperfect Compliance With Instructions for Fecal Sample Collection on Diagnostic Performance of 9 Fecal Immunochemical Tests.不遵守粪便样本采集说明对 9 种粪便免疫化学检测诊断性能的影响。
Clin Gastroenterol Hepatol. 2019 Aug;17(9):1829-1839.e4. doi: 10.1016/j.cgh.2019.03.001. Epub 2019 Mar 6.
5
Fresh vs Frozen Samples and Ambient Temperature Have Little Effect on Detection of Colorectal Cancer or Adenomas by a Fecal Immunochemical Test in a Colorectal Cancer Screening Cohort in Germany.新鲜样本与冷冻样本及室温对粪便免疫化学试验检测德国结直肠癌筛查队列中结直肠癌或腺瘤的影响较小。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1547-1556.e5. doi: 10.1016/j.cgh.2016.10.018. Epub 2016 Oct 26.
6
Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening.直接比较十种用于结直肠癌筛查的粪便免疫化学试验定量检测血红蛋白稳定性的比较。
Clin Transl Gastroenterol. 2018 Jul 6;9(7):168. doi: 10.1038/s41424-018-0035-2.
7
Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.用于检测血红蛋白的刷取粪便免疫化学检测法与基于愈创木脂的灵敏粪便潜血检测法在结直肠肿瘤检测中的比较。
Cancer. 2006 Nov 1;107(9):2152-9. doi: 10.1002/cncr.22230.
8
The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.多靶点粪便免疫化学试验与粪便免疫化学试验用于结直肠癌筛查项目:一项具有配对设计的横断面干预研究。
BMC Cancer. 2022 Dec 12;22(1):1299. doi: 10.1186/s12885-022-10372-2.
9
The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.荷兰结直肠癌筛查项目第二轮:粪便免疫化学检测截断值提高对筛查效果的影响。
Int J Cancer. 2020 Aug 15;147(4):1098-1106. doi: 10.1002/ijc.32839. Epub 2020 Jan 9.
10
Low Literacy Level Instructions and Reminder Calls Improve Patient Handling of Fecal Immunochemical Test Samples.低文化程度指导和提醒电话可改善患者对粪便免疫化学检测样本的处理。
Clin Gastroenterol Hepatol. 2019 Aug;17(9):1822-1828. doi: 10.1016/j.cgh.2018.11.050. Epub 2018 Nov 29.

引用本文的文献

1
Potential prognostic and predictive value of UBE2N, IMPDH1, DYNC1LI1 and HRASLS2 in colorectal cancer stool specimens.UBE2N、IMPDH1、DYNC1LI1和HRASLS2在结直肠癌粪便标本中的潜在预后和预测价值。
Biomed Rep. 2023 Feb 7;18(3):22. doi: 10.3892/br.2023.1604. eCollection 2023 Mar.
2
Trends of Colorectal Cancer Screening Rates in Korea: Korean National Cancer Screening Survey 2005-2020.韩国结直肠癌筛查率的趋势:韩国国家癌症筛查调查 2005-2020。
Gut Liver. 2022 Nov 15;16(6):930-941. doi: 10.5009/gnl210419. Epub 2022 Apr 22.
3
Novel Toilet Paper-Based Point-Of-Care Test for the Rapid Detection of Fecal Occult Blood: Instrument Validation Study.

本文引用的文献

1
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014.韩国癌症统计数据:2014年的发病率、死亡率、生存率及患病率
Cancer Res Treat. 2017 Apr;49(2):292-305. doi: 10.4143/crt.2017.118. Epub 2017 Mar 9.
2
Trends in Participation Rates for the National Cancer Screening Program in Korea, 2002-2012.2002 - 2012年韩国国家癌症筛查计划的参与率趋势
Cancer Res Treat. 2017 Jul;49(3):798-806. doi: 10.4143/crt.2016.186. Epub 2016 Nov 11.
3
The role of area-level deprivation and gender in participation in population-based faecal immunochemical test (FIT) colorectal cancer screening.
新型基于卫生纸的即时检测粪便潜血检测方法:仪器验证研究。
J Med Internet Res. 2020 Aug 7;22(8):e20261. doi: 10.2196/20261.
4
Increase in the Colorectal Cancer Screening Rate by a Round-Mailed Fecal Immunochemical Testing Kit and Associated Factors in Underserved Regions of Korea: A Community-Based Intervention Study.韩国服务欠缺地区通过邮寄粪便免疫化学检测试剂盒提高结直肠癌筛查率及相关因素:一项基于社区的干预研究。
Gut Liver. 2020 May 15;14(3):323-330. doi: 10.5009/gnl19124.
地区层面的贫困和性别在参与基于人群的粪便免疫化学检测(FIT)结直肠癌筛查中的作用。
Prev Med. 2016 Dec;93:198-203. doi: 10.1016/j.ypmed.2016.10.012. Epub 2016 Oct 18.
4
Colorectal Cancer Screening: Stool DNA and Other Noninvasive Modalities.结直肠癌筛查:粪便DNA及其他非侵入性检查方法
Gut Liver. 2016 Mar;10(2):204-11. doi: 10.5009/gnl15420.
5
Attitudes towards the Faecal Occult Blood Test (FOBT) versus the Faecal Immunochemical Test (FIT) for colorectal cancer screening: perceived ease of completion and disgust.对用于结直肠癌筛查的粪便潜血试验(FOBT)与粪便免疫化学试验(FIT)的态度:对完成过程的感知难易程度和厌恶感。
BMC Cancer. 2016 Feb 13;16:96. doi: 10.1186/s12885-016-2133-4.
6
Non-invasive screening for colorectal cancer in Asia.亚洲结直肠癌的非侵入性筛查
Best Pract Res Clin Gastroenterol. 2015 Dec;29(6):953-65. doi: 10.1016/j.bpg.2015.09.015. Epub 2015 Sep 26.
7
Colorectal cancer screening: a global overview of existing programmes.结直肠癌筛查:现有项目的全球概览。
Gut. 2015 Oct;64(10):1637-49. doi: 10.1136/gutjnl-2014-309086. Epub 2015 Jun 3.
8
Participation rates for organized colorectal cancer screening programmes: an international comparison.有组织的结直肠癌筛查项目的参与率:一项国际比较。
J Med Screen. 2015 Sep;22(3):119-26. doi: 10.1177/0969141315584694. Epub 2015 May 12.
9
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
10
Implementation intentions and colorectal screening: a randomized trial in safety-net clinics.实施意图与结直肠癌筛查:在安全网诊所进行的一项随机试验。
Am J Prev Med. 2014 Dec;47(6):703-14. doi: 10.1016/j.amepre.2014.08.005. Epub 2014 Nov 18.